Five Prime Therapeutics, two new leaders
This article was originally published in Scrip
Executive Summary
Innovative biologics company Five Prime Therapeutics has appointed Dr Lewis Williams president and CEO and Brian Atwood chair of the board. Dr Williams, the founder of Five Prime, was previously CSO and a director of Chiron Corporation and president of Chiron Technologies. Mr Atwood co-founded Versant Ventures, a healthcare focused venture capital firm where he serves as managing director.